User profiles for Peter Sander

Peter Sander

University of Zurich
Verified email at imm.uzh.ch
Cited by 7750

[PDF][PDF] Mycobacterium tuberculosis prevents inflammasome activation

…, S Ehlers, B Springer, GS Timmins, P Sander… - Cell host & …, 2008 - cell.com
Mycobacterium tuberculosis (Mtb) parasitizes host macrophages and subverts host innate
and adaptive immunity. Several cytokines elicited by Mtb are mediators of mycobacterial …

Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire

…, M Poidinger, F Zolezzi, L Quagliata, P Sander… - Nature …, 2014 - nature.com
Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize
conserved bacterial antigens derived from riboflavin precursors, presented by the non-polymorphic …

Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus

…, A Meier, BA Brown, Y Zhang, P Sander… - Antimicrobial Agents …, 1996 - Am Soc Microbiol
Resistance to clarithromycin among isolates of Mycobacterium chelonae and M. abscessus
was observed in 18 of 800 (2.3%) patients tested between 1990 and 1995. Patients whose …

Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance

…, K Ellrott, EC Böttger, P Sander - Antimicrobial agents …, 2001 - Am Soc Microbiol
Chromosomally acquired streptomycin resistance is frequently due to mutations in the gene
encoding the ribosomal protein S12,rpsL. The presence of several rRNA operons (rrn) and a …

A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and …

T Prammananan, P Sander, BA Brown… - Journal of Infectious …, 1998 - academic.oup.com
Twenty-six clinical isolates of Mycobacterium abscessus resistant to amikacin were identified.
Most isolates were from patients with posttympanostomy tube placement otitis media or …

Fitness cost of chromosomal drug resistance-conferring mutations

P Sander, B Springer, T Prammananan… - Antimicrobial agents …, 2002 - Am Soc Microbiol
To study the cost of chromosomal drug resistance mutations to bacteria, we investigated the
fitness cost of mutations that confer resistance to different classes of antibiotics affecting …

Laser additive manufacturing and bionics: redefining lightweight design

C Emmelmann, P Sander, J Kranz, E Wycisk - Physics Procedia, 2011 - Elsevier
New layer wise manufacturing technologies such as Laser Additive Manufacturing (LAM)
allow innovative approaches to product design. Especially for lightweight design in aircraft …

SweetWiki: A semantic wiki

M Buffa, F Gandon, G Ereteo, P Sander… - Journal of Web …, 2008 - Elsevier
Everyone agrees that user interactions and social networks are among the cornerstones of “Web
2.0”. Web 2.0 applications generally run in a web browser, propose dynamic content …

The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance

S Luthra, A Rominski, P Sander - Frontiers in microbiology, 2018 - frontiersin.org
The incidence and prevalence of non-tuberculous mycobacterial (NTM) infections have been
increasing worldwide and lately led to an emerging public health problem. Among rapidly …

A synthetic mammalian gene circuit reveals antituberculosis compounds

…, T Grau, M Daoud-El Baba, P Sander… - Proceedings of the …, 2008 - National Acad Sciences
Synthetic biology provides insight into natural gene-network dynamics and enables assembly
of engineered transcription circuitries for production of difficult-to-access therapeutic …